OCTREOTIDE MARKET ANALYSIS

Octreotide Market, by Product Type (Octreotide acetate, Octreotide chloride, indium In-111; Octreotide, and Others), by Formulation (LAR Depot form, and Immediate release Injection Form), by Application (Therapeutics (Acromegaly, Tumor, and Others), and Diagnostics), by Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies), by Region (North America, Europe, Latin America, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022-2028

To Be Published : Dec 2024
Code : CMI1836
Formats :
Excel and PDF
Industry : Pharmaceutical

Market News

Increasing number of launches pertaining to novel Octreotide acetate products by key players in the market is expected to drive market growth. For instance, in 2013, Sagent Pharmaceuticals, a U.S.-based biopharmaceutical company, launched its new drug Octreotide acetate, a samatostatin analog. This drug is used to reduce blood levels of IGF-I (soatomedinC) and growth hormone in acromegaly patients who do not adequately respond to or who cannot be treated by surgery, irradiation and bromocriptine mesylate.